Lyell Immunopharma Inc (LYEL) — Cash Flow Reinvestment Rate
Lyell Immunopharma Inc (LYEL) has a Cash Flow Reinvestment Rate of 10.70x as of December 2019, reinvesting $422.43 Million (capex $16.05 Million plus investments $-406.39 Million) from operating cash flow of $39.47 Million. Explore Lyell Immunopharma Inc (LYEL) cash conversion ratio to assess how effectively this company generates cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Lyell Immunopharma Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Lyell Immunopharma Inc across 1 annual periods. Explore how much of Lyell Immunopharma Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Lyell Immunopharma Inc (2019–2019)
Year-by-year capital reinvestment analysis for Lyell Immunopharma Inc. For live market cap and broader valuation context, see how much is Lyell Immunopharma Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 10.70x | $422.43 Million | $39.47 Million | $16.05 Million | — |